Delivery Order SPE2DB22D2206-SPE2DB25FGP92
Award Date
4/16/25
Potential Completion Date
5/7/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 120 units of the prescription drug BOSULIF 100 MG TABLET. The firm fixed price contract has a ceiling value of $5,704.45 and an ultimate completion date of June 27, 2025. The award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,815.63 contract is for the delivery of Bosulif 400 mg tablets, a prescription medication. The award has a performance period ending on June 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bosulif 400 mg tablets. The $23,631.26 firm-fixed-price contract has a completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bosulif 100 mg tablets, a medication used to treat certain types of leukemia. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $22,817.80 and a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $5,704.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 tablets of the prescription drug BOSULIF 100 MG. The contract has an ultimate completion date of June 6, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOSULIF 100 MG TABLET 120S, a prescription medication, with a firm fixed price and a ceiling value of $5,704.45. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 100 MG TABLET 120S, a prescription medication, with a ceiling value of $5,704.45. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,815.63, is for the supply of 4,567,965,360 units of the prescription medication Bosulif 400 mg tablet, with a completion date of May 9, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $9,888.50 contract is for the supply of the prescription drug Bosulif 500 mg tablets. The delivery order has a completion date of February 27, 2024 and was awarded on February 5, 2024. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp holds a larger...
This is a $11,815.63 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...